PetMed Express
$34.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$34.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.06%) As of 4:59 PM UTC today
Why Robinhood?
You can buy or sell PetMed Express and other stocks, options, and ETFs commission-free!
About PETS
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL. The listed name for PETS is PetMed Express, Inc. Common Stock.
CEO
Menderes Akdag
Employees
214
Headquarters
Delray Beach, Florida
Founded
1996
Market Cap
641.82M
Price-Earnings Ratio
22.63
Dividend Yield
3.23
Average Volume
743.95K
High Today
$35.42
Low Today
$33.50
Open Price
$35.42
Volume
324.14K
52 Week High
$57.00
52 Week Low
$21.20
PETS News
PETS Earnings
$0.00
$0.15
$0.31
$0.46
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected May 3, Pre-Market